Why Is Sportradar Stock Going Up?
Sportradar (NASDAQ:SRAD) should be on your radar for a stock…
Sell
18
HHS Quote, Financials, Valuation and Earnings
Last price:
$4.82
Seasonality move
:
3.46%
Day range:
$4.44 - $4.90
52-week range:
$4.27 - $8.87
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.19x
P/B ratio:
1.63x
Volume:
21.7K
Avg. volume:
14.8K
1-year change:
-38.02%
Market cap:
$35.4M
Revenue:
$185.2M
EPS (TTM):
-$4.17
Analysts' Opinion
-
Consensus RatingNo consensus rating exists at this time due to lack of analyst coverage.
-
Price Target UpsideNo price target exists because of limited analyst coverage.
-
Price Target DownsideSimilarly, at this time, analysts have not provided a price target so downside risk can't be assessed accurately at this time.
Fair Value
-
According to the consensus of 0 analysts, Harte-Hanks has 263.83% upside to fair value with a price target of -- per share.
HHS vs. S&P 500
-
Over the past 5 trading days, Harte-Hanks has underperformed the S&P 500 by -3.9% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Harte-Hanks does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Harte-Hanks revenues have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter Harte-Hanks reported revenues of $47.1M.
Earnings Growth
-
Harte-Hanks earnings have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter Harte-Hanks reported earnings per share of -$0.33.
Enterprise value:
25.5M
EV / Invested capital:
1.17x
Price / LTM sales:
0.19x
EV / EBIT:
4.10x
EV / Revenue:
0.14x
PEG ratio (5yr expected):
0.00x
EV / Free cash flow:
-3.78x
Price / Operating cash flow:
167.22x
Enterprise value / EBITDA:
2.40x
Gross Profit (TTM):
$128.6M
Return On Assets:
-27.25%
Net Income Margin (TTM):
-16.36%
Return On Equity:
-146.84%
Return On Invested Capital:
-146.84%
Operating Margin:
4.03%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Income Statement | ||||||
| Revenue | $206.3M | $191.5M | $185.2M | $49.5M | $47.1M | |
| Gross Profit | $144.3M | $131.9M | $128.6M | $33.1M | $32.3M | |
| Operating Income | $15.1M | $9M | $7.7M | $3.4M | $1.9M | |
| EBITDA | $17.8M | $13.3M | $10.6M | $4.6M | $3.2M | |
| Diluted EPS | $4.76 | -$0.22 | -$4.17 | -$0.27 | -$0.33 | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $86.2M | $75.4M | $66.3M | $65.2M | $53.6M | |
| Total Assets | $119.5M | $107.9M | $120M | $122.8M | $101.8M | |
| Current Liabilities | $47.2M | $42.4M | $43.6M | $48.1M | $35.1M | |
| Total Liabilities | $162.9M | $122.9M | $101.2M | $102.9M | $80.1M | |
| Total Equity | -$43.4M | -$15M | $18.8M | $19.9M | $21.7M | |
| Total Debt | $27.1M | $5M | -- | -- | -- | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $28.8M | $10.5M | -$3M | $4.4M | $4M | |
| Cash From Investing | -$11.5M | -$2.3M | -$3.7M | -$832K | -$626K | |
| Cash From Financing | -$15.8M | -$3.2M | -$419K | -$86K | -$94K | |
| Free Cash Flow | $23M | $7.7M | -$6.7M | $3M | $3.4M | |
HHS
Sector
Market Cap
$35.4M
$90.6M
Price % of 52-Week High
54.23%
65.69%
Dividend Yield
0%
0%
Shareholder Yield
0.78%
3.09%
1-Year Price Total Return
-38.02%
-13.36%
Beta (5-Year)
0.497
0.690
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Buy
Level
$4.77
200-day SMA
Sell
Level
$6.65
Bollinger Bands (100)
Sell
Level
4.9 - 6.32
Chaikin Money Flow
Sell
Level
-7.5M
20-day SMA
Sell
Level
$4.96
Relative Strength Index (RSI14)
Sell
Level
44.58
ADX Line
Sell
Level
40.93
Williams %R
Neutral
Level
-41.3043
50-day SMA
Sell
Level
$5.14
MACD (12, 26)
Sell
Level
-0.16
25-day Aroon Oscillator
Sell
Level
-88
On Balance Volume
Sell
Level
-18.5M
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (13.7752)
Sell
CA Score
(Annual)
Level (-0.955)
--
Beneish M-Score
(Annual)
Level (--)
Sell
Momentum Score
Level (3)
Sell
Ohlson Score
Level (4.0277)
Buy
Piotroski F Score
(Annual)
Level (5)
Buy
Quality Ratio Score
Level (7)
Sell
Fundamental Score
Level (3)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Harte-Hanks Inc is a customer experience company. The Company operates three business segments: Marketing Services; Customer Care; and Fulfillment & Logistics Services. The company has a geographic presence in the United States and Other countries. The majority of the revenue is earned from the United States.
Stock Forecast FAQ
In the current month, HHS has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The HHS average analyst price target in the past 3 months is --.
-
Where Will Harte-Hanks Stock Be In 1 Year?
According to analysts, the consensus estimate is that Harte-Hanks share price will rise to -- per share over the next 12 months.
-
What Do Analysts Say About Harte-Hanks?
Analysts are divided on their view about Harte-Hanks share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Harte-Hanks is a Sell and believe this share price will drop from its current level to --.
-
What Is Harte-Hanks's Price Target?
The price target for Harte-Hanks over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is HHS A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Harte-Hanks is a --. 0 of 0 analysts rate the stock a -- at this time.
-
How Can I Buy Shares Of HHS?
You can purchase shares of Harte-Hanks via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Harte-Hanks shares.
-
What Is The Harte-Hanks Share Price Today?
Harte-Hanks was last trading at $4.82 per share. This represents the most recent stock quote for Harte-Hanks. Yesterday, Harte-Hanks closed at $4.81 per share.
-
How To Buy Harte-Hanks Stock Online?
In order to purchase Harte-Hanks stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Roblox Stock a Buy, Sell or Hold?
Gaming company Roblox (NYSE:RBLX) operates a massive platform that allows…
Is Shopify a Millionaire Maker?
Shopify (NYSE:SHOP) is an eCommerce platform, business services provider and…
Stock Ideas
Buy
55
Is AAPL Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 36x
Buy
53
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Buy
51
Is NVDA Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 40x
Alerts
Sell
50
RGC alert for Mar 22
Regencell Bioscience Holdings [RGC] is up 27.82% over the past day.
Sell
36
VMI alert for Mar 22
Valmont Industries [VMI] is down 12.54% over the past day.
Buy
61
ALNY alert for Mar 22
Alnylam Pharmaceuticals [ALNY] is up 11.7% over the past day.
